BioCentury | Dec 19, 2005
Clinical News

NMP66 diagnostic data

...In a study comparing serum from breast cancer patients and healthy women, the NMP66 complex was...
...Mass. Product: NMP66 Business: Diagnostic Molecular target: NMP66 Description: Test to detect nuclear matrix protein NMP66...
BioCentury | May 30, 2005
Clinical News

Matritech preclinical data

...In 298 blinded serum samples, the qualitative RT-PCR test to detect nuclear matrix protein NMP66 identified...
...samples as 80% of those with benign breast conditions or no evidence of disease had NMP66...
...to have cancer than those with negative test values. Matritech Inc. (MZT), Newton, Mass. Product: NMP66...
BioCentury | Jan 3, 2005
Clinical News

NMP66 diagnostic data

...In 20 specimens from breast cancer patients, NMP66 test detected 7 of 8 cancers. Data were...
...Mass. Product: NMP66 Business: Diagnostic Molecular target: NMP66 Description: Test to detect nuclear matrix protein NMP66...
BioCentury | Sep 27, 2004
Company News

Matritech other research news

...Preliminary data from a serum-based NMP66 RT-PCR test detected the presence of the NMP66 protein complex...
...at the Perspectives in Breast Cancer meeting in Madrid. Matritech Inc. (MZT), Newton, Mass. Product: NMP66...
BioCentury | Oct 21, 2002
Company News

Matritech, Mitsubishi Chemical Corp. deal

...NMPS and Mitsubishi Chemical subsidiary Mitsubishi Kagaku Medical partnered to complete development of NMPS's NMP66 breast...
...Japan and offer the test for routine laboratory services once approved. The test identifes the NMP66...
BioCentury | May 28, 2002
Company News

Matritech, Bruker Daltonics deal

...The companies partnered to automate BDAL's mass spectrometry systems to run NMPS's NMP66 and NMP48 blood...
BioCentury | Jun 18, 2001
Clinical News

NMP66: Began trial

...Matritech Inc. (NMPS), Newton, Mass. Product: NMP66 Business: Diagnostics/Imaging Therapeutic category: Test Target: Nuclear matrix protein...
...Diagnostics/Imaging Therapeutic category: Test Target: Nuclear matrix protein Description: Diagnostic test for nuclear matrix protein NMP66...
...cancer with biopsy Status: NMPS began a trial in Germany to study the ability of NMP66...
BioCentury | May 29, 2001
Clinical News

NMP66: Began Trial Enrollment

...Matritech Inc. (NMPS), Newton, Mass. Product: NMP66 Business: Diagnostics/Imaging Therapeutic category: Test Target: Nuclear matrix protein...
...Diagnostics/Imaging Therapeutic category: Test Target: Nuclear matrix protein Description: Diagnostic test for nuclear matrix protein NMP66...
...300 who have had at least 2 normal mammograms to measure the ability of the NMP66...
BioCentury | Jan 2, 2001
Clinical News

Nuclear matrix protein regulatory update

...The company said the patent covers its marketed NMP22 bladder cancer test kit and its NMP66...
BioCentury | Jun 5, 2000
Clinical News

NMP66 test kit: Proof of concept study

...In 45 specimens from breast cancer patients, NMPS said that its test detected NMP66 in all...
...newly diagnosed metastatic disease and those with no lymph node involvement. The product also detected NMP66...
...Diagnostics/Imaging Therapeutic category: Test Target: NMP66 in blood Description: Diagnostic test for nuclear matrix protein NMP66...
Items per page:
1 - 10 of 13